Analysis of two different patient cohorts, one from China with mostly HBV-positive HCCs and one from Europe with mostly alcohol-, HCV- or NASH-induced HCC, which underwent liver transplantation, revealed that EGFR was expressed in liver macrophages of about 45% of HCC patients. This evidence concerns the gene EGFR and hepatocellular carcinoma.